Trial Profile
Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Patients With Poor Ovarian Response Undergoing IVF-ET, a Randomized Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Cetrorelix; Urofollitropin
- Indications Infertility
- Focus Therapeutic Use
- 01 Dec 2011 Results published in Gynecological Endocrinology.
- 11 Jul 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 11 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.